Blaustein Marc 4
4 · Finch Therapeutics Group, Inc. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Blaustein Marc
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-25+38,000→ 38,000 totalExercise: $8.61Exp: 2032-02-24→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.